Intellectual property and Licensing in Biotech

Event details

21st July 2011
Notified soon

About the event



For biotech ideas to be successful, the idea must be protected by an IP strategy that supports financing and partnering and that results in an IP portfolio that provides sufficient exclusivity to ensure a good return on investment. SMi Group provides a CPD accredited masterclass which helps delegates and their firms ensure IP success by enabling professionals to discuss the challenges and develop strategies for them.


This event covers an extensive range of topics and provides a comprehensive survey and in-depth analysis of what elements make up a successful biotech IP strategy, how biotech can best utilise IP in all stages of its development (from start-up to listed company with a mature product portfolio), how to incorporate IP into a partnering strategy, and how to deal with FTO issues should they occur. The masterclass is headed by an expert, Frank Landolt, who has in-depth knowledge and experience in licensing and IP with major pharmaceutical firms, biotech firms and research institutions.


Gaining a deeper understanding into the nature of IP is crucial in helping pharmaceutical companies in a wide range of areas including; cost-effective management of IP within biotech, learning from business models based on IP, patents and their effect on a biotech’s IP strategy, and how to deal with due diligences and freedom to operate issues.


Benefits of attending SMi’s CPD accredited masterclass, Intellectual Property and Licensing in Biotech: From Platform to Products to Partnering


Upon completion of this Masterclass, through a combination of presentations and interactive discussion, you will:


Analyse the specifics of developing a secure biotech IP strategy

Discuss in scenario driven sessions successful approaches

Debate case studies involving IP evolution, cost effectiveness and business models

Utilise expert advice on IP and strategic partnering

Gain valuable CPD points through attendance

Learn from an extremely experienced Masterclass leader with over a decade of experience in IP and pharmaceuticals


For further information and the opportunity to register online please visit;

Exhibitor information


The aim of SMi is Linking Business with Information through the delivery of high quality business to business information services. Our overriding advantage is our flexibility and ability to respond quickly to the requirements and needs of all our customers, ensuring that all SMi products are highly relevant, innovative and timely.


The SMi Group is a world leader in business to business information. Within the past year thousands of senior executives from blue chip companies benefited from SMi's highly targeted conferences, workshops and masterclasses.


As a market research based organisation, SMi takes pride in the quality of its programmes and documentation, ensuring that they are brought to the attention of the key decision makers in each industry sector in which it operates. We cultivate and maintain strong industry contacts to ensure that we are informed of all pending changes in government and regulatory policy, and we regard our relationships with speakers, delegates and subscribers as an investment for the future.